These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3308345)

  • 1. Amiodarone-associated pulmonary fibrosis. Evidence of an immunologically mediated mechanism.
    Fan K; Bell R; Eudy S; Fullenwider J
    Chest; 1987 Oct; 92(4):625-30. PubMed ID: 3308345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early pulmonary changes caused by amiodarone].
    Leipner N; Schüller H; Liesenfeld H; Noé G; Tschubel K
    Aktuelle Radiol; 1996 Sep; 6(5):235-8. PubMed ID: 8991425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse pulmonary interstitial fibrosis. Evidence of humoral antibody mediated pathogenesis.
    Fan K; D'Orsogna DE
    Chest; 1984 Feb; 85(2):150-5. PubMed ID: 6362997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone-induced pulmonary fibrosis in hamsters.
    Cantor JO; Osman M; Cerreta JM; Suarez R; Mandl I; Turino GM
    Exp Lung Res; 1984; 6(1):1-10. PubMed ID: 6734540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amiodarone-induced pulmonary fibrosis].
    Lengyel C; Boros I; Várkonyi T; Selmeczi A; Fazekas T
    Orv Hetil; 1996 Aug; 137(32):1759-62. PubMed ID: 8966018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of neferine on amiodarone-induced pulmonary fibrosis in mice.
    Niu CH; Wang Y; Liu JD; Wang JL; Xiao JH
    Eur J Pharmacol; 2013 Aug; 714(1-3):112-9. PubMed ID: 23792144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial pneumopathy and low-dosage amiodarone.
    Pozzi E; Sada E; Luisetti M; De Rose V; Scelsi M
    Eur J Respir Dis; 1984 Nov; 65(8):620-2. PubMed ID: 6519218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.
    Sobol SM; Rakita L
    Circulation; 1982 Apr; 65(4):819-24. PubMed ID: 7060263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar lavage cellular analysis and gallium lung scan in the assessment of patients with amiodarone-induced pneumonitis.
    Xaubet A; Roca J; Rodriguez-Roisin R; Herranz J; Marin A; Lomeña F; Montserrat JM; Agustí-Vidal A
    Respiration; 1987; 52(4):272-80. PubMed ID: 3438590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary fibrosis--a serious side-effect of amiodarone therapy.
    Quyyumi AA; Ormerod LP; Clarke SW; Evans TR; Ward RL
    Eur Heart J; 1983 Jul; 4(7):521-4. PubMed ID: 6628428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steroid-refractory amiodarone-induced pulmonary fibrosis. Clinical features and morphology after an amiodarone-free interval of 3 months].
    Esinger W; Schleiffer T; Leinberger H; Hertrich F; Köhler G; Gröger C; Raute-Kreinsen U
    Dtsch Med Wochenschr; 1988 Oct; 113(42):1638-41. PubMed ID: 3181014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal pulmonary toxicity occurring within two weeks of initiation of amiodarone.
    Kharabsheh S; Abendroth CS; Kozak M
    Am J Cardiol; 2002 Apr; 89(7):896-8. PubMed ID: 11909587
    [No Abstract]   [Full Text] [Related]  

  • 13. Amiodarone-induced pulmonary inflammation. Correlation with drug dose and lung levels of drug, metabolite, and phospholipid.
    Wilson BD; Clarkson CE; Lippmann ML
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1110-4. PubMed ID: 2024822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous regression of amiodarone pulmonary toxicity.
    Fraioli P; Barberis M; Montemurro L
    Sarcoidosis; 1990 Mar; 7(1):58-62. PubMed ID: 2345820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pneumonitis and pulmonary fibrosis due to amiodarone. Report of 2 cases with optic and electronic microscopy].
    Lunardi W; Lopes EA; Kehde E; Vargas FS; Pereira Júnior W; Uip DE; Cukier A; Terra Filho M; Hernández EA; Duarte MI
    Arq Bras Cardiol; 1986 Jun; 46(6):415-9. PubMed ID: 3579634
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiodarone lung: pathologic findings in clinically toxic patients.
    Myers JL; Kennedy JI; Plumb VJ
    Hum Pathol; 1987 Apr; 18(4):349-54. PubMed ID: 3557438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amiodarone and diffuse alveolar-interstitial pulmonary infiltrate. A case report].
    Moura A; Choma L; Bendhack LI
    Arq Bras Cardiol; 1984 Mar; 42(3):213-6. PubMed ID: 6477194
    [No Abstract]   [Full Text] [Related]  

  • 18. Lung disease associated with amiodarone treatment.
    Pesola A; Cosentino G; Vercillo C; De Vuono T
    G Ital Cardiol; 1985 May; 15(5):552-5. PubMed ID: 4054492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interstitial pneumopathy in subjects treated with amiodarone].
    Dezile G; Roullier A; Arbeille-Brassart B
    Presse Med; 1983 Nov; 12(43):2747-50. PubMed ID: 6228835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary toxicity of amiodarone].
    Sevillano Martín C; Callol Sánchez L; Calderón Alvarez J; Moreno Muro M; Gómez de Terreros FJ
    Rev Clin Esp; 1989 Nov; 185(7):362-5. PubMed ID: 2623252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.